Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range.

Dongchun Ni1,2 Priscilla Turelli3 Bertrand Beckert4 Sergey Nazarov4 Emiko Uchikawa4 Alexander Myasnikov4 Florence Pojer5 Didier Trono3 Henning Stahlberg1,2 Kelvin Lau5
Affiliations 5 institutions
  1. Laboratory of Biological Electron Microscopy (LBEM), Institute of Physics, School of Basic Science, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  2. Dep. of Fund. Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
  3. Laboratory of Virology and Genetics (LVG), School of Life Sciences, École polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  4. Dubochet Center for Imaging (DCI), École polytechnique Fédérale de Lausanne (EPFL) and University of Lausanne, Lausanne, Switzerland.
  5. Protein Production and Structure Characterization Core Facility (PTPSP), School of Life Sciences, École polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Abstract

Investigation of potential hosts of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is crucial to understanding future risks of spillover and spillback. SARS-CoV-2 has been reported to be transmitted from humans to various animals after requiring relatively few mutations. There is significant interest in describing how the virus interacts with mice as they are well adapted to human environments, are used widely as infection models and can be infected. Structural and binding data of the mouse ACE2 receptor with the Spike protein of newly identified SARS-CoV-2 variants are needed to better understand the impact of immune system evading mutations present in variants of concern (VOC). Previous studies have developed mouse-adapted variants and identified residues critical for binding to heterologous ACE2 receptors. Here we report the cryo-EM structures of mouse ACE2 bound to trimeric Spike ectodomains of four different VOC: Beta, Omicron BA.1, Omicron BA.2.12.1 and Omicron BA.4/5. These variants represent the oldest to the newest variants known to bind the mouse ACE2 receptor. Our high-resolution structural data complemented with bio-layer interferometry (BLI) binding assays reveal a requirement for a combination of mutations in the Spike protein that enable binding to the mouse ACE2 receptor.

Supporting text Virus Host Location
COVID-19 425 SARS-CoV-2 453 Angiotensin-Converting Enzyme 2 177 Animals 1948 Cryoelectron Microscopy 37 Host Specificity 132 Humans 1440 Mutation 209 Protein Binding 193 Spike Glycoprotein, Coronavirus 274 SARS-CoV-2 variants 86 ACE2 protein, human 87 Ace2 protein, mouse 16 spike protein, SARS-CoV-2 157

Evidence records

1 total
Functional Mechanism
1 records · 1 evidence types
Evidence type
1 records
OVE6901
Key finding

Multiple mutations in the SARS-CoV-2 Spike protein enable binding to the mouse ACE2 receptor, demonstrating molecular adaptation that expands host range.

Virus
Host
Not specified
Location
Not specified
Supporting text

Our high-resolution structural data complemented with bio-layer interferometry (BLI) binding assays reveal a requirement for a combination of mutations in the Spike protein that enable binding to the mouse ACE2 receptor.

Genes or proteins
Spike
Receptors
ACE2
Host factors
mouse ACE2
Mechanism types
receptor binding | host-range expansion